Elisabeth Ejerblad
Impact in
- Nephrology top 2%
- Chronic Kidney Disease and Diabetes
- Dialysis and Renal Disease Management
- Acute Kidney Injury Research
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 21
- Acute Myeloid Leukemia Research 18
- Hematopoietic Stem Cell Transplantation 3
- Genetics 9
- Myeloproliferative Neoplasms: Diagnosis and Treatment 8
- Co-authors
- Joseph K. McLaughlin (4 shared papers)Per Lindblad (4 shared papers)Carl Michael Fored (4 shared papers)Jon P. Fryzek (4 shared papers)Olof Nyrén (3 shared papers)Carl‐Gustaf Elinder (3 shared papers)Paul William Dickman (2 shared papers)Lisa B. Signorello (1 shared paper)
- Journals
- Blood (5 papers)British Journal of Haematology (4 papers)Leukemia (3 papers)Journal of the American Society of Nephrology (3 papers)European Journal Of Haematology (2 papers)
- Partner nations
- SwedenUnited StatesDenmark
In The Last Decade
Elisabeth Ejerblad
33 papers receiving 1.2k citations
Elisabeth Ejerblad's Hit Papers
Peers
Comparison fields: 5 of 78
- Nephrology 547
- Genetics 164
- Hematology 195
- Pharmacology 72
- Geriatrics and Gerontology 15
Countries citing papers authored by Elisabeth Ejerblad
This map shows the geographic impact of Elisabeth Ejerblad's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elisabeth Ejerblad with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elisabeth Ejerblad more than expected).
Fields of papers citing papers by Elisabeth Ejerblad
This network shows the impact of papers produced by Elisabeth Ejerblad. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elisabeth Ejerblad. The network helps show where Elisabeth Ejerblad may publish in the future.
Co-authors
The 25 scholars most cited alongside Elisabeth Ejerblad, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 33 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Obesity and Risk for Chronic Renal Failure Hit paper breakdown → | 2006 | 555 |
| 2 | 2001 | 225 | |
| 3 | 2004 | 113 | |
| 4 | 2013 | 60 | |
| 5 | 2011 | 46 | |
| 6 | 2013 | 44 | |
| 7 | 2018 | 36 | |
| 8 | 2018 | 25 | |
| 9 | 2020 | 22 | |
| 10 | 2012 | 21 | |
| 11 | 2024 | 20 | |
| 12 | 2014 | 13 | |
| 13 | 2004 | 12 | |
| 14 | 2022 | 12 | |
| 15 | 2023 | 12 | |
| 16 | 2020 | 11 | |
| 17 | 2021 | 10 | |
| 18 | 2021 | 6 | |
| 19 | 2009 | 5 | |
| 20 | 2012 | 4 |
About Elisabeth Ejerblad
Elisabeth Ejerblad is a scholar working on Hematology, Genetics, Nephrology, Radiology, Nuclear Medicine and Imaging and Health, having authored 33 papers that have together received 1.3k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (18 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers), Chronic Kidney Disease and Diabetes (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Acute Kidney Injury Research (2 papers), Nephrotoxicity and Medicinal Plants (2 papers), Health disparities and outcomes (1 paper) and Inflammatory mediators and NSAID effects (1 paper). The work is most often cited by research in Nephrology (547 citations), Genetics (164 citations), Hematology (195 citations), Pharmacology (72 citations) and Geriatrics and Gerontology (15 citations). Elisabeth Ejerblad has collaborated with scholars based in Sweden, United States and Denmark. Frequent co-authors include Joseph K. McLaughlin, Per Lindblad, Carl Michael Fored, Jon P. Fryzek, Olof Nyrén, Carl‐Gustaf Elinder, Paul William Dickman, Lisa B. Signorello, Loren Lipworth and Matthew M. Zack. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Journal of the American Society of Nephrology and European Journal Of Haematology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.